CAVA: Dizziness Trial
NCT: NCT04026516 · COMPLETED
Brief Summary
Clinical investigation of a medical device (CAVA) for recording eye movements. Patients suffering from diagnosed dizziness conditions will wear the device for 23 hours a day, for 30 days. The device will capture normal eye movement data as well as data corresponding to any dizzy events experienced. At the end of the trial, the data will be downloaded and a scientist will perform a blinded analysis of the data. Specifically, they will attempt to identify the dates on which dizziness was reported.
Frequently Asked Questions
What is CAVA: Dizziness Trial?
CAVA: Dizziness Trial is a clinical trial registered under NCT04026516. Current status: COMPLETED.
What is the status of NCT04026516?
The current status of NCT04026516 (CAVA: Dizziness Trial) is: COMPLETED.
When did CAVA: Dizziness Trial start?
CAVA: Dizziness Trial started on 2019-07-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.